Cargando…
GRNDaD: big data and sickle cell disease
Big data are used in the pursuit of precision medicine in the general population. Applying these tools to patients with sickle cell disease (SCD) is essential for ensuring that they receive the most appropriate customized therapy for their disease. For these tools to be applied, there must be a larg...
Autores principales: | Lanzkron, Sophie, Manwani, Deepa, Desai, Payal, Kanter, Julie, Little, Jane |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8945321/ https://www.ncbi.nlm.nih.gov/pubmed/35133406 http://dx.doi.org/10.1182/bloodadvances.2021005282 |
Ejemplares similares
-
PI-01: GRNDAD AND COUSIN: INVESTIGATOR-INITIATED COLLABORATIONS TO IMPROVE CARE IN SICKLE CELL DISEASE
por: J., LITTLE, et al.
Publicado: (2022) -
Investigational curative gene therapy approaches to sickle cell disease
por: Williams, David A., et al.
Publicado: (2021) -
The management of venous thromboembolism in hospitalized patients with COVID-19
por: Spyropoulos, Alex C.
Publicado: (2020) -
COVID-19 coagulopathy vs disseminated intravascular coagulation
por: Levi, Marcel
Publicado: (2020) -
Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?
por: Arruda, Valder R.
Publicado: (2021)